Intended for healthcare professionals

Rapid response to:

News

Collaboration with drug industry won’t affect clinical decisions, says new guide

BMJ 2012; 344 doi: https://doi.org/10.1136/bmj.e2489 (Published 02 April 2012) Cite this as: BMJ 2012;344:e2489

Rapid Response:

Re: Collaboration with drug industry won’t affect clinical decisions, says new guide

You state in this article that the Ethical Standards in Health and Life Sciences Group "points out that the industry was responsible for 92% of drug research and development in 2009 and that it takes 10-15 years and typically costs £550m (€660m; $880m) to develop a new drug." I would be interested to know where these figures came from. They look suspiciously like those that Marcia Angell dealt with a few years ago.1
Have none of them read Marcia Angell's dismantling of this claim? Her analysis reveals how these figures are grossly inflated, how most new drugs are 'me-too' derivatives, how very few innovative drugs are produced now and that most of these come from academic institutions. I can't see that much has changed
Is the former editor of the New England Journal of Medicine someone who can be ignored? Or is all that in the past and the likes of Vioxx forgotten?

1.Marcia Angell. The Truth about Drug Companies. 2005 Random House

Competing interests: No competing interests

20 April 2012
Richard Stenning
Patient
none
n/a